Skip to main content

Table 1 Evolutionary rate estimates for the complete and the reduced-age data sets of 10 viruses

From: Declining transition/transversion ratios through time reveal limitations to the accuracy of nucleotide substitution models

 

Mean rate and 95% credible interval (substitutions/site/year)

Virus data set and number of sequences (reduced-age/complete data)

Complete data set

Reduced-age data set

ASFV (22/50)

3.61 × 10−5 (3.31 × 10−5 – 4.29 × 10−5)

4.58 × 10−5 (3.39 × 10−5 – 1.40 × 10−4)

BYDV (17/27)

2.39 × 10−5 (1.94 × 10−5 – 3.46 × 10−3)

2.81 × 10−5 (2.12 × 10−5 – 4.62 × 10−5)

CaPV (20/37)

6.50 × 10−5 (6.04 × 10−5 – 7.11 × 10−5)

8.56 × 10−5 (6.17 × 10−5 – 2.21 × 10−4)

CYDV (45/76)

1.79 × 10−3 (1.75 × 10−4 – 7.89 × 10−3)

2.35 × 10−3 (2.57 × 10−4 – 761 × 10−3)

DENV-4 (32/49)

1.12 × 10−3 (5.38 × 10−5 – 4.09 × 10−3)

1.51 × 10−3 (7.48 × 10−5 – 4.23 × 10−3)

EBOV (17/32)

3.89 × 10−4 (1.92 × 10−4 – 7.15 × 10−4)

4.75 × 10−4 (1.99 × 10−4 – 1.11 × 10−3)

HBV (15/34)

2.06 × 10−4 (1.51 × 10−4 – 3.90 × 10−4)

2.34 × 10−4 (1.54 × 10−4 – 6.78 × 10−4)

HIV-1 (17/29)

3.21 × 10−3 (2.59 × 10−3 – 4.15 × 10−3)

4.06 × 10−3 (2.62 × 10−3 – 8.59 × 10−3)

RABV (16/48)

4.56 × 10−4 (3.48 × 10−4 – 6.64 × 10−4)

5.33 × 10−4 (3.36 × 10−4 – 1.05 × 10−3)

HIV-2 + SIV (18/30)

1.03 × 10−3 (6.79 × 10−4 – 1.56 × 10−3)

1.42 × 10−3 (7.00 × 10−4 – 4.54 × 10−3)

  1. The abbreviations correspond to those in Figure 1.